InvestorsHub Logo
Followers 4
Posts 1191
Boards Moderated 0
Alias Born 10/03/2015

Re: NY1972 post# 211

Sunday, 05/22/2016 11:51:51 PM

Sunday, May 22, 2016 11:51:51 PM

Post# of 977
PD-L1 antibody in urothelial bladder cancer

ORR was 25% (3/12) in pts with liver metastases and 50% (4/8) in pts with lymph node?only disease. Responses are ongoing in 15/16 pts; longest duration of response is ongoing at 11.3+ mos (median not reached).

http://abstracts.asco.org/176/AbstView_176_163749.html